[Bacteriological and pharmacological properties of new cephalosporin antibiotics. I. Cephalothin. 2].
D001419:Bacteria / Q000187:drug effects*; D002512:Cephalothin / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012475:Salmonella / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects
D002512:Cephalothin
Bakteriologische und pharmakologische Eigenschaften der neuen Cephalosporin-Antibiotica. I. Cephalothin. 2.